Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans

Journal of Molecular Medicine

Volumn 86, Issue 3, 2008, Pages 303-311

  Voruganti, V Saroja ^a   Lopez Alvarenga, Juan C ^a   Nath, Subrata D ^b   Rainwater, David L ^a   Bauer, Richard ^b   Cole, Shelley A ^a   MacCluer, Jean W ^a   Blangero, John ^a   Comuzzie, Anthony G ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Genetic correlations; Insulin resistance; Variance component approach

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 12Q; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISPANIC; HOMEOSTATIC MODEL ASSESSMENT METHOD; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; TECHNIQUE; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; LOD SCORE; MALE; MEXICAN AMERICANS; MIDDLE AGED; PHENOTYPE; VARIATION (GENETICS);

EID: 39849090009     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0273-3     Document Type: Article

References (52)

1. Ferrannini E (2006) Is insulin resistance the cause of the metabolic syndrome? Ann Med 38:42-51
2. Schinner S, Scherbaum WA, Bornstein SR, Barthel A (2005) Molecular mechanisms of insulin resistance. Diabet Med 22:674-682
3. Hong Y, Despres JP, Rice T, Nadeau A, Province MA, Gagnon J et al (2000) Evidence of pleiotropic loci for fasting insulin, total fat mass and abdominal visceral fat in a sedentary population: The HERITAGE family study. Obes Res 8:151-159
4. Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD et al (2003) Genetic Epidemiology of insulin resistance and visceral adiposity: the IRAS family study design and methods. Am J Epidemiol 13:211-217
5. Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106:453-458
6. Krebs M, Roden M (2005) Molecular mechanism of lipid-induced insulin resistance in muscle, liver and vasculature. Diab Obes Metab 7:621-632
7. Nigro J, Osman N, Dart AM, Little PJ (2006) Insulin resistance and atherosclerosis. Endocrine Reviews 27:242-259
8. Rader DJ (2007) Effect of insulin resistance, dyslipidemia and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12-S18
9. Haffner SM, Stern MP, Hazuda HP, Rosenthal M, Knapp JA, Malina RM (1986) Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites. Diabetes Care 9:153-161
10. Duggirala RN, Blangero J, Almasy A, Arya R, Dyer TD, Williams KL et al (2001) A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican-Americans. Am J Hum Genet 68:1149-1164
11. Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF (2002) Cardiovascular disease mortality in Hispanics and non-Hispanic Whites. Am J Epidemiol 156:919-928
12. Lorenzo C, Williams K, Hunt KJ, Haffner SM (2006) Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care 29:625-630
13. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ (1984) Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 120:834-851
14. Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK (1990) Risk factors for cardiovascular mortality in Mexican-Americans and non-Hispanic Whites: The San Antonio Heart Study. Am J Epidemiol 131:423-433
15. Mitchell BD, Kammerer CM, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD et al (1996) Genetic Analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 16:281-288
16. Comuzzie AG, Mitchell BD, Cole SA, Martin LJ, Hsueh WC, Rainwater DL et al (2003) The Genetics of obesity in Mexican-Americans: the evidence from genome scanning efforts in the San Antonio Family Heart Study. Hum Biol 75:635-646
17. Comuzzie AG, Blangero J, Mahaney MC, Haffner SM, Mitchell BD, Stern MP, MacCluer JW (1996) Genetics and environmental correlations among hormone levels and measures of body fat accumulation and topography. J Clin Endocrinol Metab 81:597-600
18. Matthews DR, Hosker JP, Rudensky AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting glucose and insulin concentrations in man. Diabetologia 28:412-419
19. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW (2005) Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring study. Diabetes 54:3252-3257
20. MacCluer JW, Stern MP, Almasy L, Atwood LA, Blangero J, Comuzzie AG et al (1999) Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev 57:S59-S65
21. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D (1999) Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100:354-360
22. Miller WG, Waymack PP, Anderson FP, Ethridge SF, Jayne EC (2002) Performance of four homogenous direct methods for LDL-cholesterol. Clin Chem 48:1812-1814
23. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
24. Hopper JL, Mathews JD (1982) Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 46:373-383
25. Blangero J, Almasy L (1997) Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol 14:959-964
26. Self SG, Liang KY (1987) Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assoc 82:605-610
27. Almasy L, Dyer TD, Blangero J (1997) Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol 14:953-958
28. Bach I, Galcheva-Gargova Z, Mattei M-G, Simon-Chazottes D, Guenet J-L, Cereghini S et al (1990) Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse. Genomics 8:155-164
29. Tonooka N, Tomura H, Takahashi Y, Onigata K, Kikuchi N, Horikawa Y et al (2002) High frequency of mutations in the HNF-1α gene (TCF1) in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance. Diabetologia 45:1709-1712
30. Morton CC, Byers MG, Nakai H, Bell GI, Shows TB (1986) Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-24.1, 11p15 and 4q25-27. Cytogenet Cell Genet 41:245-249
31. Yang-Feng TL, Brissende JE, Ullrich A, Francke U (1985) Sub-regional localization of human genes for insulin-like growth factors I (IGF1) and II (IGF2) by in situ hybridization. Cytogenet Cell Genet 40:782
32. Sun G, Gagnon J, Chagnon YC, Perusse L, Despres JP, Leon AS et al (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE family study. Int J Obes Relat Metab Disord 23(9):929-935
33. Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH (1997) Structure and localization of the human gene encoding SR-BI/CLA-1: evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272:33068-33076
34. Ullrich CK, Widmer J, Park JP, Mohandas TK, Witters LA (1997) Assignment of acetyl-CoA carboxylase-beta (ACACB) to human chromosome band 12q24.1 by in situ hybridization. Cytogenet cell genet 77:176-177
35. Pedeutour F, Szpirer C, Nahon JL (1994) Assignment of the human pro-melanin-concentrating hormone gene (PMCH) to chromosome 12q23-24 and two variant genes (PMCHL1 and PMCHL2) to chromosome 5p14 and 5q12-q13. Genomics 19:31-37
36. Mills GW, Avery PJ, McCarthy MI, Hattersley AT, Levy JC, Hitman GA et al (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia. 47:732-738
37. An P, Freedman BI, Hanis CL, Chen YI, Weder AB, Schork NJ et al (2005) Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Diabetes. 54:909-914
38. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullstrom M et al (1997) Characterization of the MODY3 phenotype. J Clin Invest 99:582-591
39. Shaw JTE, Lovelock PK, Kesting JB, Cardinal J, Duffy D, Wainwright B, Cameron DP (1998) Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 47:1793-1796
40. Lindgren CM, Mahtani MM, Widen E, McCarthy MI, Daly MJ, Kirby A et al (2002) Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: The Botnia study. Am J Hum Genet 70:509-516
41. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB et al (1997) Linkage of genetic markers on human chromosome 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46:882-886
42. Rich SS, Bowden DW, Haffner SM, Norris JM, Saad MF, Mitchell BD et al (2004) Identification of quantitative trait loci for glucose homeostasis. The Insulin Resistance Atherosclerosis study (IRAS). Family study. Diabetes 53:1866-1875
43. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL et al (2000) Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 66:1871-1881
44. Van Tilburg JH, Sandkuijl LA, Franke L, Strengman E, Pearson PL, van Haeften TW et al (2003) Genome-wide screen in obese pedigrees with type2 diabetes mellitus from a defined Dutch population. Eur J Clin Invest 33:1070-1074
45. Lewis CE, North KE, Arnett D, Borecki IB, Coon H, Ellison RC et al (2005) Sex-specific findings from a genome-wide linkage analysis of human fatness in non-Hispanic whites and African-Americans: The HyperGEN study. Intl J Obes 29:639-649
46. Cai G, Cole SA, Freeland-Graves JH, MacCluer JW, Blangero J, Comuzzie AG (2004) Genome-wide scans reveal quantitative trait loci on 8p and 13q related to insulin action and glucose metabolism: The San Antonio Family Heart Study. Diabetes 53:1369-1374
47. Hanley AJG, Williams K, Stern MP, Haffner SM (2002) Homeostatic model assessment of insulin resistance in relation to the incidence of cardiovascular disease. Diabetes Care 25:1177-1184
48. Sundquist J, Winkleby MA (1999) Cardiovascular risk factors in Mexican-American adults: a transcultural analysis of NHANES III, 1988-1994. Am J Public Health 89:723-730
49. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB et al (2007) Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: The Bruneck study. Diabetes Care 30:318-324
50. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S (2007) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 49:2112-2119
51. Rader DJ (2007) Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12-S18
52. Bertoni AG, Wong ND, Shea S, Ma S, Liu K, Srikanthan P et al (2007) Insulin resistance, Metabolic syndrome and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes Care 30:2951-2956